ACCD Accolade

Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference

Accolade to Participate in 39th Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the 39th Annual J.P. Morgan Healthcare Conference, including a presentation on Thursday, January 14, 2021 at 2:50 p.m. E.T. An audio webcast and related presentation materials will be available at ir.accolade.com.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support from Accolade Health Assistants® and Clinicians, and integrated data and programs across mobile, online and phone, Accolade navigates people through the healthcare system with trust, empathy and ease. Employers offer Accolade to employees and their families as the single place to turn for all health, healthcare, and benefits questions or concerns, increasing their engagement in benefits and connecting them to high-quality providers and care. By empowering members to make better decisions about their health, Accolade can support members in lowering the cost and complexity of healthcare while achieving consumer satisfaction ratings over 90 percent and an NPS of 60.

Investor Contact:

Todd Friedman, Investor Relations, 484-532-5200,

Asher Dewhurst, Investor Relations, 443-213-0503,

Media Contact:

Megan Torres, Public Relations, 206-926-8180,

Source: Accolade        



EN
11/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Accolade

 PRESS RELEASE

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results SEATTLE, April 03, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal fourth quarter 2024 financial results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking . () Upon registering, you will be emailed a dial-in numb...

 PRESS RELEASE

Accolade To Present at Upcoming Investor Conferences

Accolade To Present at Upcoming Investor Conferences SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: Raymond James 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5 at 8:05 am ETBarclays 26th Annual Global Healthcare Conference in Miami Beach on Wednesday, March 13 at 1:35 pm ET A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personaliz...

 PRESS RELEASE

Accolade Announces Results for Fiscal Third Quarter 2024

Accolade Announces Results for Fiscal Third Quarter 2024 SEATTLE, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023. “As we head into the new year, Accolade continues to define the future of how healthcare should be experienced in this country. Our unique combination of people and technology is creating a new model for improving health outcomes and helping our more than 10 million members live healthier lives. We are closing the physician gap, improving access to care, and leveraging AI a...

 PRESS RELEASE

Accolade To Present at Upcoming Investor Conferences

Accolade To Present at Upcoming Investor Conferences SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences: 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 11 at 7:30am PT26th Annual Needham Growth Conference in New York on Thursday, January 18 at 3:00pm ET A webcast of these events will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personalized Healthcare company...

 PRESS RELEASE

Accolade to Announce Fiscal Third Quarter 2024 Financial Results

Accolade to Announce Fiscal Third Quarter 2024 Financial Results SEATTLE, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2024 financial results on Monday, January 8, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking (). Upon registering, you will be emailed a dial-in number, dire...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch